More on HALO
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $106.49 |
|
|||
| Open | $107.45 | ||||
| 52 Wk High | $18.39 | ||||
| 52 Wk Low | $6.96 | ||||
| Day High | $108.53 | ||||
| Day Low | $106.87 | ||||
| P/E | N/A | ||||
| EPS | $-0.58 | ||||
| Volume | 1,058,643 | ||||
- Form 3 HALOZYME THERAPEUTICS, For: Aug 14 Filed by: Appelhans Dannielle
- Form 4 HALOZYME THERAPEUTICS, For: Aug 17 Filed by: Torley Helen
- Form 8-K HALOZYME THERAPEUTICS, For: Aug 14
- Halozyme adds biotech executive Appelhans to its board
- Halozyme Appoints Dannielle Appelhans to its Board of Directors
- H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
- Form 144 HALOZYME THERAPEUTICS, Filed by: Torley Helen
- Form 144 HALOZYME THERAPEUTICS, Filed by: Caudill Cortney
- Form 4 HALOZYME THERAPEUTICS, For: Aug 10 Filed by: Connaughton Bernadette
- Form 144 HALOZYME THERAPEUTICS, Filed by: Connaughton Bernadette
Entities mentioned with HALO
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- S3 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
